infomeddnews4d
Carl Marks Securities Successfully Advises Kewaunee Scientific Corporation on $55 Million Acquisition of Nu Aire
Complementary Acquisition Expands Kewaunee’s Product Offerings and Market Reach Carl Marks Securities, an affiliate of middle market investment bank Carl Marks Advisors, today announced that it has ...
infomeddnews5d
Exactech Reports the FDA Clearance of Truliant® Porous 3D Tibial Implant for Knee Replacement Surgery
Exactech, a global medical technology leader, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Truliant® Porous Tibial Tray, a 3D tibial knee ...
infomeddnews5d
Jay Hallinan Appointed Chief Commercial Officer of Q’Apel Medical
Q’Apel Medical (Q’Apel), a private medical device company focused on revolutionizing neurovascular interventions, announced today the appointment of seasoned medical device executive Jay Hallinan as ...
infomeddnews5d
Bright Uro Announces Oversubscribed $32M Series A Funding Round
Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms (LUTS) through innovations in urodynamics, today announced the second closing of its Series A ...
infomeddnews6d
Elixir Medical Reports | LithiX HC-IVL System Data Demonstrate Sustained Safety and Efficacy at Six Months
Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced positive six-month data from the PINNACLE I study evaluating the safety and performance of its ...
infomeddnews7d
GT Metabolic Solutions Announces FDA Clearance of their GT Metabolic’s MagDI™ System
GT Metabolic Solutions Inc., the global leader in magnetic compression anastomosis surgery, announced today that the U.S. Food and Drug Administration (FDA) cleared GT Metabolic’s MagDI™ System for ...
infomeddnews7d
Immorta Bio Reports | SenoVax™ Reduces Growth and Stops Metastasis of Aggressive Breast Cancer Using its First-In-Class Immune Stimulatory Therapy
Immorta Bio, a scientific longevity company focused on “Treating Diseases of Aging and Treating Aging as Disease™,” announced today successful treatment of aggressive breast cancer in animal models ...
infomeddnews7d
Robert Guigley Is Appointed Chief Commercial Officer of DELFI Diagnostics
Industry Leader to Drive Adoption of Breakthrough Blood-Based Technology and Fragmentomics Platform for Improved Screening and Monitoring DELFI Diagnostics, Inc., developer of accessible blood-based ...
infomeddnews8d
Avania — Building a MedTech Advisory & Clinical Development Partner | By: Jason Monteleone, Chief Executive Officer & President of Avania
The MedTech industry continues to thrive and innovate. According to Markets and Market’s “The Global MedTech Industry Outlook 2024” report, the MedTech market is expected to grow 4% in 2024 to $668.2B ...
infomeddnews8d
Edwards Lifesciences | Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients
Edwards Lifesciences today announced results from the EARLY TAVR Trial, the first randomized, controlled trial designed to study the best strategy for treating asymptomatic severe aortic stenosis (AS) ...
infomeddnews8d
Alcohol Addiction Treatment in Killeen, Texas: Your Path to Recovery
Alcohol addiction, also known as alcohol use disorder (AUD), is a medical condition where an individual becomes unable to control their drinking. It goes beyond casual drinking or occasional ...
infomeddnews8d
Dramatic Drop in Marijuana Use Among U.S. Youth Over a Decade: (2011 to 2021)
FAU Study Also Finds Changing Landscapes of Use by Gender, Race/Ethnicity Marijuana has emerged as one of the most commonly used illicit substances among adolescents in the United States. Given the ...